{
    "Trade/Device Name(s)": [
        "COULTER\u00ae LIN-X Linearity Control"
    ],
    "Submitter Information": "Beckman Coulter, Inc",
    "510(k) Number": "K081641",
    "Predicate Device Reference 510(k) Number(s)": [
        "K955334",
        "K061064",
        "K942822"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPK"
    ],
    "Summary Letter Date": "January 5, 2009",
    "Summary Letter Received Date": "January 6, 2009",
    "Submission Date": "June 6, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology Quality Control Mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White Blood Cells (WBC)",
        "Red Blood Cells (RBC)",
        "Hemoglobin (HGB)",
        "Platelets (PLT)"
    ],
    "Specimen Type(s)": [
        "Human blood components"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COULTER cellular analysis systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for COULTER LIN-X linearity control for calibration and reportable range assessment of COULTER cellular analysis systems",
    "Indications for Use Summary": "Intended to assess calibration and verify the reportable range of COULTER cellular analysis systems in conjunction with specific COULTER reagents",
    "fda_folder": "Hematology"
}